Promoting informed decision making about prostate cancer screening

E C Chan

doi:10.1007/s12019-001-0014-4

Promoting informed decision making about prostate cancer screening

Compr Ther. 2001 Fall;27(3):195-201. doi: 10.1007/s12019-001-0014-4.

Author

E C Chan¹

Affiliation

¹ Division of General Internal Medicine, Department of Medicine, University of Texas-Houston Health Science Center, 6431 Fannin, 1.122 MSB, Houston, TX 77030, USA.

PMID: 11569319
DOI: 10.1007/s12019-001-0014-4

Abstract

Because prostate cancer screening with prostate specific antigen is controversial, informed consent is recommended. Physicians are encouraged to discuss facts about prostate specific antigen with patients and to supplement such discussions with informational brochures or videotapes.

Publication types

Review

MeSH terms

Biomarkers
Decision Making*
Humans
Informed Consent*
Male
Mass Screening / psychology*
Patient Education as Topic / methods
Physician-Patient Relations
Prostate-Specific Antigen*
Prostatic Neoplasms / diagnosis*
United States

Substances

Biomarkers
Prostate-Specific Antigen